Rubric Capital Management LP Sutro Biopharma, Inc. Transaction History

Rubric Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$3.29 - $4.9 $2.32 Million - $3.45 Million	-703,934 Reduced 17.39%	3,344,810 $11.6 Million
Q2 2023 Aug 11, 2023	SELL	$4.25 - $5.88 $1.32 Million - $1.83 Million	-311,743 Reduced 7.15%	4,048,744 $18.8 Million
Q1 2023 May 12, 2023	BUY	$4.48 - $8.45 $5.15 Million - $9.71 Million	1,148,615 Added 35.76%	4,360,487 $20.1 Million
Q4 2022 Feb 10, 2023	BUY	$5.41 - $8.08 $9.8 Million - $14.6 Million	1,811,872 Added 129.42%	3,211,872 $26 Million
Q3 2022 Nov 14, 2022	BUY	$5.17 - $7.11 $2.59 Million - $3.56 Million	500,000 Added 55.56%	1,400,000 $7.77 Million
Q2 2022 Aug 15, 2022	BUY	$3.41 - $8.95 $3.07 Million - $8.05 Million	900,000 New	900,000 $4.69 Million

136

62.4M

77.1K

31.4K

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $139M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

Get notified when there are updates to the investment portfolio of Rubric Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Rubric Capital Management LP with notifications on news.